High-tech Development: Net profit attributable to parent companies in the first quarter was 34.4979 million yuan, a year-on-year increase of 9.68%

Related posts

• Dongfeng Technology: Net profit in the first quarter of 2024 was 14.6946 million yuan, a year-on-year increase of 37.76%

  Dongfeng Technology (600081) disclosed its first quarter report for 2024 on April 26. In the first quarter of 2024, the company achieved total operating income of 1.573 billion yuan, a year-on-year increase of 5.01%; net profit attributable to the parent company was 14.6946 million yuan, a year-on-year increase of 37.76%; non-net profit after deduction was 2.0046 million yuan, a year-on-year decrease of 72.69%; Net cash flow was 69.9454 million yuan, a year-on-year decrease of 50.28%; during the reporting period, Dongfeng Technology\’s basic earnings per share was 0.0254 yuan, and the weighted average return on net assets was 0.32%.

  US stock market April 25, 2024

• Jagsonpal Pharma introduces new product; shares rise

  Jagsonpal Pharmaceuticals Ltd’s shares were up by 4.71 per cent after the company announced the launch of MemUp, a hormone replacement therapy (HRT) featuring a USFDA-approved combination of bioidentical estradiol and bioidentical progesterone in a single daily oral capsule. MemUp aims to address vasomotor symptoms of menopause, such as hot flashes, night sweats, and sleep issues.

  US stock market May 24, 2024

• Gift Nifty signals flat-to-positive opening; low participation expected

  As we approach the weekend, domestic markets are anticipated to open flat on Friday. It’s worth noting that market participation is expected to remain low, primarily due to the long weekend holidays. This is because the market will be closed on Monday for local polling related to the general election, a factor that could influence trading volumes and market dynamics.

  US stock market May 17, 2024

• Strides Pharma Science’s shares rise 1.64% on USFDA approval

  Strides Pharma Science Limited’s shares rose 1.64 per cent after the company announced that its subsidiary, Strides Pharma Global Pte Limited, Singapore, received approval from the USFDA for Sevelamer Carbonate Tablets, 800 mg.

  US stock market May 10, 2024

• Satellite operator AST soared over 45% and cooperated with AT&T to provide satellite communication services

  Gelonghui, May 16 | Satellite operator AST SpaceMobile (ASTS.US) soared over 45% to US$3.47

  US stock market May 16, 2024

• Shanshi Network Technology: Loss of 75.4048 million yuan in the first quarter of 2024

  CSI Intelligent Financial Information Shanshi Network Technology (688030) disclosed its first quarter report for 2024 on April 26. In the first quarter of 2024, the company achieved total operating income of 151 million yuan, a year-on-year increase of 4.49%; net profit attributable to the parent company was a loss of 75.4048 million yuan, a loss of 87.4564 million yuan in the same period last year; a loss after deducting non-net profits was 75.7863 million yuan, a loss in the same period last year 91.9258 million yuan; the net cash flow generated from operating activities was -10.7085 million yuan, compared with -12.6281 million yuan in the same period last year; during the reporting period, Shanshi Network\’s basic earnings per share was -0.4184 yuan, and the weighted average return on net assets was -7.26%.

  US stock market April 25, 2024